| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.097 | 0.08 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |